Clinical trial · Interventional
Exploratory Study of Toumai Endoscopic Surgery System for Remote Gastrectomy
NCT06073483CI-TRIAL-00070364unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This clinical study was a prospective, single-center, single-arm exploratory study. Subjects who meet the inclusion criteria will be enrolled in this study, where surgeons will perform 5G remote gastrectomy on subjects using the Toumai endoscopic surgery system, and explore and evaluate the safety and efficacy of this clinical application.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gastric Cancer | Malignant Gastric Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Toumai Endoscopic surgery System | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- 5G remote gastrectomy
- interventionNames
- Device: Toumai Endoscopic surgery System
Primary outcomes (2)
- measure
- The rate of intraoperative complications
- timeFrame
- The day of surgery
- description
- Intraoperative complications, including organ injury and vascular injury, were evaluated using the Satava grading system to determine whether the occurrence of complications was related to the study instrument or surgery
- measure
- The rate of postoperative complications
- timeFrame
- Postoperative 30 days
- description
- Postoperative complications, including postoperative bleeding, fever, and incisional infection, were evaluated using the Clavien-Dindo grading system to determine whether the occurrence of complications was related to the study instrument or surgery.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: 1. 18 years old ≤ actual age ≤80 years old. 2. Patients requiring gastrointestinal endoscopic surgery. 3. Willing to cooperate with and complete the study follow-up and related examinations. 4. Voluntarily participate in the study and sign the informed consent in person. Exclusion Criteria: 1. Have serious cardiovascular or circulatory disease and cannot tolerate surgery. 2. Participated in other clinical trials within the last 3 months. 3. Inability to understand trial requirements, or inability to complete the study follow-up plan. 4. Researchers believe that there are other circumstances that are not suitable for inclusion.
References
Publications (0)
Data not yet available
No reference posted for this study.